Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Health Network, Toronto
With
Princess Margaret Hospital, Canada
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Patients with clinical stage T1-T4 carcinoma of the prostate
Must have undergone radical radiation and at least 2 years of Pharmacological androgen ablation.Pharmacological androgen ablation may include: LHRH-agonists with or without Non-steroidal androgen ablation, Steroidal Anti-androgens, Progestational agents, and Cypoterone (Androcur).
Must be currently 6 months or more after their last injection of LHRH-agonists if it was being given every 3 months or 4 months or more after their last injection, if it was being given monthly. If the patient was on oral androgen ablation agent, they must be off this medication for a period of at least 4 months.
currently off hormonal therapy
Able to sign the consent form and fill out questionnaire used in the study.
You may not be if
No patients who have been treated, or are currently being treated with Bicalutamide
no previous orchidectomy.
Clareo Health | Erectile Dysfunction/Prostate/RT/Androgen
